27th May 2021 16:21
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | UDG HEALTHCARE PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 26 May 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
5,355,737 | 2.13% | 267,333 | 0.11% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
227,940 | 0.09% | 4,898,413 | 1.94% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
5,583,677 | 2.22% | 5,165,746 | 2.05% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 213 | 10.5550 GBP |
Purchase | 265 | 10.5400 GBP |
Purchase | 289 | 10.5503 GBP |
Purchase | 325 | 10.5546 GBP |
Purchase | 475 | 10.5378 GBP |
Purchase | 557 | 10.5300 GBP |
Purchase | 1,219 | 10.5479 GBP |
Purchase | 3,331 | 10.5600 GBP |
Purchase | 3,386 | 10.5500 GBP |
Purchase | 3,397 | 10.5324 GBP |
Purchase | 3,461 | 10.6100 GBP |
Purchase | 4,128 | 10.5398 GBP |
Purchase | 5,110 | 10.5265 GBP |
Purchase | 5,214 | 10.5307 GBP |
Purchase | 8,167 | 10.5281 GBP |
Purchase | 9,914 | 10.5275 GBP |
Purchase | 12,663 | 10.5336 GBP |
Purchase | 19,643 | 10.5200 GBP |
Purchase | 62,982 | 10.5326 GBP |
Purchase | 103,807 | 10.5248 GBP |
Sale | 24 | 10.5500 GBP |
Sale | 60 | 10.5800 GBP |
Sale | 147 | 10.5400 GBP |
Sale | 204 | 10.5791 GBP |
Sale | 206 | 10.5550 GBP |
Sale | 208 | 10.5356 GBP |
Sale | 232 | 10.5600 GBP |
Sale | 234 | 10.5307 GBP |
Sale | 408 | 10.5230 GBP |
Sale | 1,095 | 10.5200 GBP |
Sale | 1,164 | 10.6100 GBP |
Sale | 1,657 | 10.5300 GBP |
Sale | 2,358 | 10.5322 GBP |
Sale | 3,094 | 10.5421 GBP |
Sale | 3,244 | 10.5203 GBP |
Sale | 3,547 | 10.5234 GBP |
Sale | 3,754 | 10.5701 GBP |
Sale | 7,982 | 10.5212 GBP |
Sale | 8,379 | 10.5305 GBP |
Sale | 16,602 | 10.5290 GBP |
Sale | 22,965 | 10.5328 GBP |
Sale | 100,970 | 10.5279 GBP |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities | Price per |
| unit | |||
SWAP | Long | 1,266 | 10.5300 GBP |
SWAP | Long | 3,163 | 10.5299 GBP |
SWAP | Long | 4,622 | 10.5464 GBP |
CFD | Long | 9,026 | 10.5389 GBP |
SWAP | Long | 13,439 | 10.5288 GBP |
CFD | Short | 2,108 | 10.6085 GBP |
SWAP | Short | 10,531 | 10.5379 GBP |
SWAP | Short | 12,443 | 10.5338 GBP |
SWAP | Short | 13,261 | 10.5268 GBP |
SWAP | Short | 47,506 | 10.5310 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 27 May 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210527005681/en/
Copyright Business Wire 2021
Related Shares:
BarclaysUDG.L